- Home
- DUKR vs CRIS Comparison
DUKR vs CRIS Comparison
Compare DUKR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.24
HOLD
Current Price
$5.02
Company Overview
Basic Information| Metric | DUKR | CRIS |
|---|---|---|
| Founded | N/A | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 20.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | DUKR | CRIS |
|---|---|---|
| Price | $5.24 | $5.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 20.0K | ★ 182.1K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $4.75 | $0.18 |
| 52 Week High | $7.41 | $6.74 |
Technical Indicators
Market Signals| Indicator | DUKR | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 34.52 | 68.47 |
| Support Level | $4.90 | $0.66 |
| Resistance Level | $5.74 | $5.50 |
| Average True Range (ATR) | 0.42 | 0.49 |
| MACD | 0.03 | -0.12 |
| Stochastic Oscillator | 19.61 | 51.01 |
Price Performance
Historical Comparison DUKR
CRIS
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.